Vitiligo;Vitiligo

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 16, 1997, Pages 759-764

  Njoo, M D ^a   Westerhof, W ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

DEPIGMENTATION; DISEASE COURSE; HUMAN; MELANOCYTE; PHOTOCHEMISTRY; SHORT SURVEY; VITILIGO;

ADOLESCENT; ADULT; AUTOIMMUNE DISEASES; CHILD; FEMALE; HUMANS; MALE; MELANOCYTES; PUVA THERAPY; VITILIGO;

EID: 0030925079     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (19)

1. Mosher DB, Fitzpatrick TB, Hori Y, Ortonne JP. Disorders of melanocytes. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Frank Austen K, editors. Dermatology in general medicine. New York: McGraw Hill Book Company, 1993:903-96.
2. Westerhof W, Bolhaar B, Menke HE, Harper JI. Resultaten van een enquête onder vitiligopatiënten. Ned Tijdschr Dermatol Venereol 1996;6:100-5.
3. Porter J, Beuf AH, Lerner A, Nordlund J. Response to cosmetic disfigurement: patients with vitiligo. Cutis 1987;39:493-4.
4. Westerhof W. Differential Diagnose bei Vitiligo - ein Bildbericht. Aktuelle Dermatol 1993;19:80-6.
5. Ortonne JP, Bose SK. Vitiligo: where do we stand? Pigment Cell Res 1993;6:61-72.
6. Salzer BA, Schallreuter KU. Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism. Dermatology 1995;190:109-15.
7. Lerner AB. On the etiology of vitiligo and gray hair. Am J Med 1971;51:141-7.
8. Schallreuter KU, Wood JM, Ziegler I, Lemke KR, Pittelkow MR, Lindsey NJ, Gutlich M. Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. Biochim Biophys Acta 1994;1226:181-92.
9. Le Poole IC, Das PK, Wijngaard RM van den, Bos JD, Westerhof W. Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 1993;2:145-53.
10. El Mofty AM. A preliminary report on the treatment of leukoderma with Ammi Majus Linn. J R Egypt Med Assoc 1948;31:651-65.
11. Nieuweboer-Krobotova L, Westerhof W. Behandeling van vitiligo met UVB (311 nm). Ned Tijdschr Dermatol Venereol [ter perse].
12. Grimes PE. Vitiligo. An overview of therapeutic approaches. Dermatol Clin 1993;11:325-38.
13. Falabella R, Arrunategui A, Barona MI, Alzate A. The minigrafting test for vitiligo: detection of stabile lesions for melanocyte transplantation. J Am Acad Dermatol 1995;32:228-32.
14. Boersma BR, Westerhof W, Bos JD. Repigmentation in vitiligo vulgaris by autologous minigrafting: results in nineteen patients. J Am Acad Dermatol 1995;33:990-5.
15. Kahn AM, Cohen MJ. Vitiligo: treatment by dermabrasion and epithelial sheet grafting. J Am Acad Dermatol 1995;33:646-8.
16. Falabella R, Escobar C, Borrero I. Transplantation of in vitro cultured epidermis bearing melanocytes for repigmenting vitiligo. J Am Acad Dermatol 1989;21:257-64.
17. Mosher DB, Parrish JA, Fitzpatrick TB. Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature. Br J Dermatol 1977;97:669-79.
18. Reynolds JEF, editor. Martindale. The Extra Pharmacopoeia. 31th ed. London: the Pharmaceutical Press, 1996.
19. Thissen M, Westerhof W. Laser treatment for further depigmentation in vitiligo. Int J Dermatol [ter perse].